The SIDP Podcast
3 months ago

#71 – This is a Potential Breakup Song: Controversies in the Management of Infective Endocarditis

Episode Notes

Episode Notes

Inspired by lamentations on Twitter, Drs. Bobbi Jo Stoner (@BobbiJo_Stoner), Jonathan Ryder (@JonathanRyderMD) and Sami El-Dalati join Dr. Jillian Hayes (@thejillianhayes) to hash out some of the controversies we encounter while managing infective endocarditis. Do we really need gentamicin and rifampin for all cases of staphylococcal prosthetic valve endocarditis? Where do oral antimicrobials fit into this disease state? Who should have a seat at the table to provide the most comprehensive care to these patients? Tune in for the answers to these questions and more!

Learn more about the Society of Infectious Diseases Pharmacists: Twitter: @SIDPharm ( Instagram: @SIDPharm ( Facebook: LinkedIn:

Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed:

References: IDSA/AHA Infective Endocarditis Guidelines: Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis: Twitter Poll – Gabe Vilchez (March 2021): Survey of ID Physicians on Gent and Rifampin Use: Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis: Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus: Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations: Rifampin Combination Therapy for Nonmycobacterial Infections: ARREST Trial: Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study: Nephrotoxicity of vancomycin, alone and with an aminoglycoside: Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia: Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments: CERT Trial (in process): Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study: A step-by-step guide to implementing a multidisciplinary endocarditis team: Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement from the American Heart Association: Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases: A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity: POET Trial: Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis: Comparing right- and left sided injection-drug related infective endocarditis: Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections: Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna: Impact of the duration of antibiotic therapy on relapse and survival following surgery for active infective endocarditis: Bacteriological Outcome after Valve Surgery for Active Infective Endocarditis: Implications for Duration of Treatment after Surgery: Long-term Risk of Hemorrhagic Stroke in Patients With Infective Endocarditis: A Danish Nationwide Cohort Study: Sign of the Times: Updating Infective Endocarditis Diagnostic Criteria to Recognize Enterococcus faecalis as a Typical Endocarditis Bacterium: Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study:

Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.